Asciminib and bosutinib efficacy in CML-CP patients: a comparison study
Andreas Hochhaus • 27 Nov 2020
Asciminib has the potential to succeed where other TKIs have failed in CML
Michael Mauro • 1 Jun 2018
What is the best treatment in the next few years to achieve more treatment-free remission in CML?
Michele Baccarani • 11 Jun 2016